Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Children's Oncology Group
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Korean Society of Hematology
Enliven Therapeutics
Novartis
City of Hope Medical Center
Shenzhen TargetRx Co., Ltd.
Augusta University
Takeda
University of California, Irvine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Hospitalier Henri Duffaut - Avignon
M.D. Anderson Cancer Center
Novartis
City of Hope Medical Center
University of Michigan Rogel Cancer Center